Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreased pulse rate01:14

Decreased pulse rate

841
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
841
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

894
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
894
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

2.7K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.7K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

1.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.6K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

566
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
566

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The link between father presence and critical thinking disposition of college students: The mediating role of self-esteem and the moderating role of gender.

Acta psychologica·2026
Same author

Therapeutic effects of jaceosidin on atopic dermatitis via ubiquitin-mediated JAK1 degradation.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Comparative metagenomic analysis of gut microbiomes in Yunnan ponies and Dutch warmblood horses.

Frontiers in microbiology·2026
Same author

ILA-CSMA: Hybrid Sensing and Adaptive Fair Backoff for Large-Scale LoRa Networks.

Sensors (Basel, Switzerland)·2026
Same author

A BAI1-PSTB-Hydrogel promotes diabetic wound healing by targeting mtDNA leakage and the cGAS-STING axis to alleviate endothelial senescence.

Bioactive materials·2026
Same author

Individualized regulation of inflatable laryngeal mask airway cuff pressure reduces postoperative pharyngolaryngeal pain in elderly patients: a randomized controlled trial.

Frontiers in medicine·2026
Same journal

Elevated plasma TMAO levels associated with all-cause mortality in CAD patients in South China.

BMC cardiovascular disorders·2026
Same journal

Balloon aortic valvuloplasty for critical aortic stenosis in neonates and infants: early outcomes from a single-center cohort.

BMC cardiovascular disorders·2026
Same journal

Association between glucose-to-platelet ratio and all-cause mortality in critically ill patients with acute myocardial infarction: a retrospective cohort study.

BMC cardiovascular disorders·2026
Same journal

Association of lipoprotein(a) with left ventricular dysfunction in patients with chronic total occlusion of the coronary artery.

BMC cardiovascular disorders·2026
Same journal

Ten-year trends in cardiovascular risk factors among patients hospitalised with acute myocardial infarction in Estonia: a retrospective nationwide observational study.

BMC cardiovascular disorders·2026
Same journal

Oral anticoagulant prescribing and DOAC dosing appropriateness in patients with non-valvular atrial fibrillation: a retrospective study from Vietnam.

BMC cardiovascular disorders·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
12:41

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat

Published on: August 28, 2021

4.8K

Why does dexmedetomidine cause bradycardia?

Yanfang Liu1, Xiaobei Ma1, Wenjie Cheng2

  • 1Department of Anesthesiology, Tianjin Hospital, Tianjin, 300211, China.

BMC Cardiovascular Disorders
|October 14, 2025
PubMed
Summary
This summary is machine-generated.

Dexmedetomidine (Dex) causes bradycardia by decreasing heart rate and increasing vagal nerve activity. It also directly impacts sinoatrial node cells, reducing firing rate and action potential amplitude.

Keywords:
Adverse reactionBradycardiaDexmedetomidineHemodynamics

More Related Videos

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
07:42

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates

Published on: October 18, 2018

6.6K
Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

14.1K

Related Experiment Videos

Last Updated: Jan 15, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
12:41

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat

Published on: August 28, 2021

4.8K
Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
07:42

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates

Published on: October 18, 2018

6.6K
Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

14.1K

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology

Background:

  • Dexmedetomidine is an alpha-2 adrenergic agonist used for sedation and anesthesia.
  • Bradycardia is a common side effect of dexmedetomidine administration.

Purpose of the Study:

  • To elucidate the underlying mechanisms of dexmedetomidine-induced bradycardia.
  • To investigate the effects of dexmedetomidine on cardiac electrophysiology and autonomic nervous system activity.

Main Methods:

  • A rabbit model was used, with animals divided into groups receiving different doses of dexmedetomidine or a sham treatment.
  • Heart rate and vagal efferent nerve discharge were monitored.
  • Action potentials of sinoatrial node cells were measured after exposure to varying concentrations of dexmedetomidine.

Main Results:

  • Dexmedetomidine significantly decreased heart rate and increased vagal efferent discharge in a dose-dependent manner.
  • Dexmedetomidine exhibited negative chronotropic effects on sinoatrial node pacemaker cells.
  • Concentration-dependent reductions in action potential amplitude and firing rate, along with prolonged action potential duration, were observed.

Conclusions:

  • Dexmedetomidine induces bradycardia through both central and peripheral mechanisms.
  • The drug directly affects sinoatrial node function, contributing to its bradycardic effects.